Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD
Tongji University · University at Buffalo, State University of New York
Abstract
Bile acids are regulators of lipid and glucose metabolism, and modulate inflammation in the liver and other tissues. Primary bile acids such as cholic acid and chenodeoxycholic acid (CDCA) are produced in the liver, and converted into secondary bile acids such as deoxycholic acid (DCA) and lithocholic acid by gut microbiota. Here we investigated the possible roles of bile acids in non-alcoholic fatty liver disease (NAFLD) pathogenesis and the impact of the gut microbiome on bile acid signalling in NAFLD.
Serum bile acid levels and fibroblast growth factor 19 (FGF19), liver gene expression profiles and gut microbiome compositions were determined in patients with NAFLD, high-fat diet-fed rats and their controls.
Citation impact
- FWCI
- 23.98
- Percentile
- 100%
- References
- 52
Authors
12- NJNa Jiao
Tongji University
- SSSusan S. BakerCorresponding
University at Buffalo, State University of New York
- ACAdrián Chapa‐Rodríguez
University at Buffalo, State University of New York
- WLWensheng Liu
University at Buffalo, State University of New York
- CAColleen A. Nugent
University at Buffalo, State University of New York
Topics & keywords
- FGF19
- Farnesoid X receptor
- Deoxycholic acid
- Bile acid
- Internal medicine
- Chenodeoxycholic acid
- Cholic acid
- CYP8B1
- Good health and well-being